X-120530154-CTAAG-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001079872.2(CUL4B):c.2536_2539delCTTA(p.Leu846fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 23)
Consequence
CUL4B
NM_001079872.2 frameshift
NM_001079872.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.95
Genes affected
CUL4B (HGNC:2555): (cullin 4B) This gene is a member of the cullin family. The encoded protein forms a complex that functions as an E3 ubiquitin ligase and catalyzes the polyubiquitination of specific protein substrates in the cell. The protein interacts with a ring finger protein, and is required for the proteolysis of several regulators of DNA replication including chromatin licensing and DNA replication factor 1 and cyclin E. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0565 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-120530154-CTAAG-C is Pathogenic according to our data. Variant chrX-120530154-CTAAG-C is described in ClinVar as [Pathogenic]. Clinvar id is 817034.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-120530154-CTAAG-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUL4B | NM_001079872.2 | c.2536_2539delCTTA | p.Leu846fs | frameshift_variant | 19/20 | ENST00000371322.11 | NP_001073341.1 | |
CUL4B | NM_003588.4 | c.2590_2593delCTTA | p.Leu864fs | frameshift_variant | 21/22 | NP_003579.3 | ||
CUL4B | NM_001330624.2 | c.2551_2554delCTTA | p.Leu851fs | frameshift_variant | 20/21 | NP_001317553.1 | ||
CUL4B | NM_001369145.1 | c.2002_2005delCTTA | p.Leu668fs | frameshift_variant | 19/20 | NP_001356074.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUL4B | ENST00000371322.11 | c.2536_2539delCTTA | p.Leu846fs | frameshift_variant | 19/20 | 1 | NM_001079872.2 | ENSP00000360373.5 | ||
CUL4B | ENST00000681206.1 | c.2650_2653delCTTA | p.Leu884fs | frameshift_variant | 22/23 | ENSP00000505480.1 | ||||
CUL4B | ENST00000680673.1 | c.2590_2593delCTTA | p.Leu864fs | frameshift_variant | 21/22 | ENSP00000505084.1 | ||||
CUL4B | ENST00000681253.1 | c.2590_2593delCTTA | p.Leu864fs | frameshift_variant | 22/23 | ENSP00000506259.1 | ||||
CUL4B | ENST00000681652.1 | c.2590_2593delCTTA | p.Leu864fs | frameshift_variant | 24/25 | ENSP00000505176.1 | ||||
CUL4B | ENST00000336592.11 | c.2551_2554delCTTA | p.Leu851fs | frameshift_variant | 20/21 | 5 | ENSP00000338919.6 | |||
CUL4B | ENST00000674137.11 | c.2542_2545delCTTA | p.Leu848fs | frameshift_variant | 19/20 | ENSP00000501019.6 | ||||
CUL4B | ENST00000681090.1 | c.2443_2446delCTTA | p.Leu815fs | frameshift_variant | 19/20 | ENSP00000506288.1 | ||||
CUL4B | ENST00000679927.1 | c.2191_2194delCTTA | p.Leu731fs | frameshift_variant | 20/21 | ENSP00000505603.1 | ||||
CUL4B | ENST00000371323.3 | c.2002_2005delCTTA | p.Leu668fs | frameshift_variant | 19/20 | 5 | ENSP00000360374.3 | |||
CUL4B | ENST00000680474.1 | c.1978_1981delCTTA | p.Leu660fs | frameshift_variant | 18/20 | ENSP00000505562.1 | ||||
CUL4B | ENST00000679844.1 | c.1873_1876delCTTA | p.Leu625fs | frameshift_variant | 17/18 | ENSP00000505239.1 | ||||
CUL4B | ENST00000404115.8 | c.2439+2264_2439+2267delCTTA | intron_variant | 1 | ENSP00000384109.4 | |||||
CUL4B | ENST00000673919.1 | n.*1983_*1986delCTTA | non_coding_transcript_exon_variant | 20/21 | ENSP00000500994.1 | |||||
CUL4B | ENST00000674073.2 | n.*92_*95delCTTA | non_coding_transcript_exon_variant | 17/18 | ENSP00000501262.2 | |||||
CUL4B | ENST00000679405.1 | n.*1745_*1748delCTTA | non_coding_transcript_exon_variant | 21/22 | ENSP00000504985.1 | |||||
CUL4B | ENST00000679432.1 | n.*1745_*1748delCTTA | non_coding_transcript_exon_variant | 21/22 | ENSP00000505343.1 | |||||
CUL4B | ENST00000680918.1 | n.*1452_*1455delCTTA | non_coding_transcript_exon_variant | 17/18 | ENSP00000505955.1 | |||||
CUL4B | ENST00000681080.1 | n.*1745_*1748delCTTA | non_coding_transcript_exon_variant | 19/20 | ENSP00000505898.1 | |||||
CUL4B | ENST00000681189.1 | n.*702_*705delCTTA | non_coding_transcript_exon_variant | 19/20 | ENSP00000505973.1 | |||||
CUL4B | ENST00000681333.1 | n.*3429_*3432delCTTA | non_coding_transcript_exon_variant | 16/17 | ENSP00000505739.1 | |||||
CUL4B | ENST00000681908.1 | n.*708_*711delCTTA | non_coding_transcript_exon_variant | 19/20 | ENSP00000505777.1 | |||||
CUL4B | ENST00000673919.1 | n.*1983_*1986delCTTA | 3_prime_UTR_variant | 20/21 | ENSP00000500994.1 | |||||
CUL4B | ENST00000674073.2 | n.*92_*95delCTTA | 3_prime_UTR_variant | 17/18 | ENSP00000501262.2 | |||||
CUL4B | ENST00000679405.1 | n.*1745_*1748delCTTA | 3_prime_UTR_variant | 21/22 | ENSP00000504985.1 | |||||
CUL4B | ENST00000679432.1 | n.*1745_*1748delCTTA | 3_prime_UTR_variant | 21/22 | ENSP00000505343.1 | |||||
CUL4B | ENST00000680918.1 | n.*1452_*1455delCTTA | 3_prime_UTR_variant | 17/18 | ENSP00000505955.1 | |||||
CUL4B | ENST00000681080.1 | n.*1745_*1748delCTTA | 3_prime_UTR_variant | 19/20 | ENSP00000505898.1 | |||||
CUL4B | ENST00000681189.1 | n.*702_*705delCTTA | 3_prime_UTR_variant | 19/20 | ENSP00000505973.1 | |||||
CUL4B | ENST00000681333.1 | n.*3429_*3432delCTTA | 3_prime_UTR_variant | 16/17 | ENSP00000505739.1 | |||||
CUL4B | ENST00000681908.1 | n.*708_*711delCTTA | 3_prime_UTR_variant | 19/20 | ENSP00000505777.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 17, 2024 | Frameshift variant predicted to result in abnormal protein length as the last 50 amino acid(s) are replaced with 12 different amino acid(s), and other similar variants have been reported in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25385192) - |
CUL4B-related disorder Other:1
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant interpreted as Likely pathogenic and reported on 10-13-2018 by GeneDx. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Philip Payne PhD, FACMI from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at